Ann: Invitation to Investor Briefing, page-20

Hi All, bought in this afternoon.  Hoping the XanADu trial is successful & Xanamem offers a promising treatment option for Alzheimer’s Disease.  Pretty amazing a small Aussie biotech seems to be progressing well, whilst Big Pharmas  are removing research in this area from R & D Depts.  Let’s hope ACW have a breakthrough in the works.

I have some more reading to do on the ‘intricacies’ of Xanamem & the trial, but so far looks really good.

https://www.nia.nih.gov/alzheimers/clinical-trials/xanamem-mild-alzheimers-disease

Unfortunately won’t be able to make it to the investor presentation in Sydney on 22/3, would have been a good opportunity especially for a new investor.  GLTAH